CareDx Announces Q2 2026 Financial Performance
CareDx Reports Strong Second Quarter 2026 Results with 52% Revenue Growth and Raises Full-Year Financial Outlook CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company focused on transplant medicine,…
Meitheal Pharmaceuticals Receives FDA Approval for Garzulys™ Injection
Meitheal Pharmaceuticals Secures FDA Approval for Garzulys™ Biosimilar Insulin to Expand Diabetes Care in the U.S. Meitheal Pharmaceuticals, Inc., a Chicago-based biopharmaceutical company focused on the development and commercialization of…
PVP Labs to Showcase Taphalgin® at 2026 Military Health System Research Symposium
PVP Labs to Present Taphalgin® Research at 2026 Military Health System Research Symposium, Highlighting a Novel Battlefield Pain Management Approach PVP Labs, a clinical-stage biotechnology company focused on developing innovative…
Feinstein Institutes Scientists Discover the Brain’s Breathing Alarm System
Feinstein Institutes Researchers Discover the Brain’s Respiratory Alarm Mechanism Researchers at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a previously unknown brain circuit that continuously monitors every breath…
miRecule and Rio Biopharma Partner to Advance Targeted RNA Therapeutics
miRecule and Rio Biofarma Brasil Partner to Advance Next-Generation RNA Delivery Technologies miRecule, Inc., a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases, has entered into…
Cofactor Genomics Appoints Dr. Howard Bailey as Chief Medical Officer
Cofactor Genomics Appoints Renowned Oncologist Dr. Howard H. Bailey as Chief Medical Officer to Advance Precision Immunotherapy Diagnostics Cofactor Genomics, a commercial-stage diagnostics company focused on advancing precision oncology through…
Johnson & Johnson and Sail Biomedicines Partner to Advance In Vivo CAR-T Therapies
Johnson & Johnson Partners with Sail Biomedicines to Advance In Vivo CAR-T Therapies for Immune-Mediated Diseases Johnson & Johnson has announced a broad strategic collaboration with Sail Biomedicines, a biotechnology…
Latigo Biotherapeutics Reports Positive LTG-001 Trial Results Published in NEJM
Latigo Biotherapeutics Publishes Positive Phase 2 LTG-001 Acute Pain Trial Results in The New England Journal of Medicine Latigo Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative non-opioid…
Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine Receives EU Authorization
Pfizer and BioNTech Receive European Commission Approval for 2026–2027 XFG-Adapted COVID-19 Vaccine Across Europe Pfizer Inc. and BioNTech SE have announced that the European Commission (EC) has granted marketing authorization…
Teleflex Receives FDA Approval for EZPLAZ™ Freeze-Dried Plasma
Teleflex Receives Historic FDA Approval for EZPLAZ™ Freeze Dried Plasma, Expanding Emergency Blood Transfusion Options Teleflex Incorporated, a global leader in medical technology and innovative healthcare solutions, has announced a…
VDyne Treats First Patient in Pivotal TRIVITA Study of TriNova™ System
VDyne Launches Pivotal TRIVITA Study, Treats First Patient with TriNova™ Transcatheter Tricuspid Valve Replacement System VDyne Inc., a privately held medical device company focused on advancing structural heart therapies, has…
PK MED Strengthens Leadership to Advance Therapeutic Micro-Implant Development
PK MED Strengthens Leadership and Scientific Governance to Advance ARTHRELIS and ENGRAFTIS Development Programs PK MED, a French biotechnology company established by healthcare investment firm Truffle Capital, has announced a…